iMetabolic Biopharma Corporation is now taking investment for its Seed Investment Round. These funds will support 10 months of product development and operations, at which time the lead candidate (iMBP-001) is expected have completed non-GMP/GLP production and testing.
This offer is extended to any accredited investor interested in participating in the Biopharmaceutical start-up space. Interested parties are encouraged to request a company prospectus and investor package by sending the iMBP Corp team a message through the Contact Us page. If you are unsure if you qualify as an Accredited Investor, please follow the link below to the US Securities and Exchange Commission (SEC) webpage for a full list of financial requirements.